SNSE Stock Summary and Trading Ideas (Sensei Biotherapeutics | NASDAQ:SNSE)

Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.

Sensei Biotherapeutics trades on the NASDAQ stock market under the symbol SNSE.

As of May 1, 2026, SNSE stock price climbed to $26.96 with 28,373 million shares trading.

SNSE has a beta of 0.20, meaning it tends to be less sensitive to market movements. SNSE has a correlation of 0.00 to the broad based SPY ETF.

SNSE has a market cap of $36.16 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, SNSE traded as high as $38.80 and as low as $5.00.

The top ETF exchange traded funds that SNSE belongs to (by Net Assets): VXF, DFAS, DFMC.

SNSE has outperformed the market in the last year with a return of +237.3%, while the SPY ETF gained +30.4%. In the last 3 month period, SNSE beat the market returning +183.8%, while SPY returned +4.4%. However, in the most recent 2 weeks SNSE has underperformed the stock market by returning -11.6%, while SPY returned +1.5%.

SNSE support price is $24.49 and resistance is $28.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNSE shares will trade within this expected range on the day.